Skip to main content
    U

    U.S. Physical Therapy, Inc. (USPH)

    Official site

    HEALTHCARE • MEDICAL CARE FACILITIES • NYSE

    $99.58
    -0.02 (-0.02%)

    Market Cap: $1.49B

    Last updated: Nov 17, 2026 at 11:05 AM ET

    U.S. Physical Therapy, Inc. (USPH) Earnings: Report Dates and Results

    Updated Nov 4, 2026. Results come from company earnings reports, and estimates are consensus analyst estimates.

    U.S. Physical Therapy (USPH) is expected to report earnings on Feb 23, 2027. In the quarter ended Sep 30, 2026, U.S. Physical Therapy reported EPS of $0.80, above the $0.76 estimate. It beat the EPS estimate in 3 of the last 8 quarters.

    Earnings

    Performance (10Y)

    Beat Rate
    57%(23/40)
    Avg Surprise
    +9.72%
    Streak
    1 Q

    Upcoming Estimates

    Reports Feb 23, 2027 (est.)Period ending Dec 31, 2026
    EPS Consensus$0.90
    Range$0.76 - $1.04
    9 analysts
    Revenue Consensus
    $233.73M
    Range$214.95M - $262.95M
    9 analysts
    Reports May 4, 2027 (est.)Period ending Mar 31, 2027
    EPS Consensus$0.54
    Range$0.47 - $0.60
    2 analysts
    EPS Revisions
    1
    1
    30d
    EPS Estimate DriftChange to current
    90d ago$0.54-0.3%
    60d ago$0.50+7.0%
    30d ago$0.51+4.9%
    7d ago$0.51+4.9%
    Current$0.54
    Revenue Consensus
    $220.40M
    Range$215.89M - $224.61M
    3 analysts

    Next Report

    USPH has an expected report date of Feb 23, 2027. Analysts' consensus for the quarter ending Dec 31, 2026 is 34.3% above the $0.67 reported for the quarter ended Dec 31, 2025.

    USPH Earnings Call

    The latest USPH earnings call transcript on file is labeled 2026Q3.

    Read the 2026Q3 transcript

    Earnings History

    Of the 40 quarters below that had an estimate, USPH beat 23, missed 14 and matched 3. Revenue for the quarter ended Sep 30, 2026 was $222.56M, up 12.9% from $197.13M a year earlier.

    Quarter endedEPSEstimateRangeSurpriseResultYoYAnalystsRevisionsReportedRevenue
    Sep 30, 2026$0.80$0.76$0.57 - $0.90+5.26%Beat+21.2%61 up, 1 downNov 4, 2026$222.56M
    Jun 30, 2026$0.75$0.85$0.78 - $0.91-11.76%Miss-7.4%50 up, 0 downAug 5, 2026$214.06M
    Mar 31, 2026$0.46$0.52$0.35 - $0.64-11.54%Miss-4.2%70 up, 0 downMay 6, 2026$198.29M
    Dec 31, 2025$0.67$0.67$0.61 - $0.73-0.56%Miss+31.4%61 up, 0 downFeb 25, 2026$202.73M
    Sep 30, 2025$0.66$0.67$0.59 - $0.73-1.49%Miss-4.3%53 up, 1 downNov 5, 2025$197.13M
    Jun 30, 2025$0.81$0.69$0.62 - $0.78+17.39%Beat+11.0%50 up, 6 downAug 6, 2025$197.34M
    Mar 31, 2025$0.48$0.45$0.34 - $0.63+6.67%Beat-5.9%60 up, 4 downMay 7, 2025$183.79M
    Dec 31, 2024$0.51$0.70$0.56 - $0.77-26.78%Miss-13.6%72 up, 3 downFeb 26, 2025$180.45M
    Sep 30, 2024$0.69$0.68$0.61 - $0.73+1.47%Beat+11.3%60 up, 0 downNov 5, 2024$168.03M
    Jun 30, 2024$0.73$0.82$0.74 - $0.89-10.98%Miss-3.9%60 up, 0 downAug 13, 2024$167.19M
    Mar 31, 2024$0.51$0.56$0.46 - $0.67-8.93%Miss-13.6%60 up, 0 downMay 7, 2024$155.68M
    Dec 31, 2023$0.59$0.57$0.48 - $0.66+3.51%Beat+1.7%60 up, 0 downFeb 28, 2024$154.80M
    Sep 30, 2023$0.62$0.62$0.56 - $0.660.00%In line+6.9%60 up, 0 downNov 7, 2023$150.01M
    Jun 30, 2023$0.76$0.75$0.71 - $0.80+1.33%Beat-15.6%50 up, 0 downAug 8, 2023$151.49M
    Mar 31, 2023$0.59$0.55$0.49 - $0.62+7.27%Beat-9.2%40 up, 0 downMay 3, 2023$148.51M
    Dec 31, 2022$0.58$0.57$0.54 - $0.62+1.75%Beat-19.4%40 up, 0 downFeb 22, 2023$141.18M
    Sep 30, 2022$0.58$0.56$0.48 - $0.60+3.57%Beat-31.8%51 up, 0 downNov 2, 2022$139.60M
    Jun 30, 2022$0.90$0.95N/A-5.26%Miss-6.2%N/A0 up, 0 downAug 4, 2022$140.66M
    Mar 31, 2022$0.65$0.63$0.60 - $0.66+3.17%Beat+1.6%40 up, 1 downMay 5, 2022$131.70M
    Dec 31, 2021$0.72$0.69$0.65 - $0.71+4.35%Beat-15.3%5N/AFeb 24, 2022$129.83M
    Sep 30, 2021$0.85$0.78$0.73 - $0.85+8.97%Beat0.0%5N/ANov 4, 2021$125.89M
    Jun 30, 2021$0.96$0.71$0.68 - $0.79+35.21%Beat+146.2%5N/AAug 5, 2021$126.93M
    Mar 31, 2021$0.64$0.47$0.24 - $0.58+36.17%Beat+113.3%5N/AMay 6, 2021$112.37M
    Dec 31, 2020$0.85$0.83$0.71 - $0.89+2.41%Beat+32.8%5N/AFeb 25, 2021$117.47M
    Sep 30, 2020$0.85$0.51$0.40 - $0.67+66.67%Beat+19.7%5N/ANov 5, 2020$108.93M
    Jun 30, 2020$0.39-$0.18-$0.28 - -$0.06+316.67%Beat-51.9%4N/AAug 6, 2020$83.86M
    Mar 31, 2020$0.30$0.32$0.04 - $0.72-6.25%Miss-54.5%5N/AMay 21, 2020$112.72M
    Dec 31, 2019$0.64$0.69$0.67 - $0.70-7.25%Miss-9.9%6N/AFeb 27, 2020$122.11M
    Sep 30, 2019$0.71$0.71$0.70 - $0.720.00%In line+10.9%6N/ANov 7, 2019$117.25M
    Jun 30, 2019$0.81$0.81$0.79 - $0.820.00%In line+68.8%6N/AAug 8, 2019$126.37M
    Mar 31, 2019$0.66$0.61$0.58 - $0.62+8.20%Beat+144.4%6N/AMay 2, 2019$116.23M
    Dec 31, 2018$0.71$0.63$0.59 - $0.64+12.70%Beat+44.9%6N/AMar 7, 2019$109.56M
    Sep 30, 2018$0.64$0.58$0.55 - $0.60+10.34%Beat+33.3%7N/ANov 1, 2018$113.12M
    Jun 30, 2018$0.48$0.68$0.64 - $0.70-29.41%Miss-18.6%7N/AAug 2, 2018$115.10M
    Mar 31, 2018$0.27$0.56$0.52 - $0.61-51.79%Miss-43.7%7N/AMay 3, 2018$116.13M
    Dec 31, 2017$0.49$0.47$0.38 - $0.52+4.26%Beat+6.5%7N/AMar 8, 2018$134.03M
    Sep 30, 2017$0.48$0.49$0.42 - $0.55-2.04%Miss+4.3%7N/ANov 2, 2017$103.03M
    Jun 30, 2017$0.59$0.56$0.54 - $0.64+5.36%Beat+3.5%7N/AAug 3, 2017$104.25M
    Mar 31, 2017$0.48$0.47$0.43 - $0.50+2.13%Beat+11.6%6N/AJun 7, 2017$97.56M
    Dec 31, 2016$0.46$0.47$0.45 - $0.49-2.13%Miss-4.2%6N/AMar 2, 2017$98.57M
    Last 40 quarters

    Annual EPS

    EPS for the fiscal year ended Dec 31, 2025 was $2.62, up 7.4% from the year before. It was $1.92 for the year ended Dec 31, 2016, the oldest of the 10 fiscal years shown.

    Fiscal year endedEPSChange
    Dec 31, 2025$2.62+7.4%
    Dec 31, 2024$2.44-4.7%
    Dec 31, 2023$2.56-5.5%
    Dec 31, 2022$2.71-14.5%
    Dec 31, 2021$3.17+32.6%
    Dec 31, 2020$2.39-15.2%
    Dec 31, 2019$2.82+34.3%
    Dec 31, 2018$2.10+2.9%
    Dec 31, 2017$2.04+6.3%
    Dec 31, 2016$1.92N/A

    Earnings Calls

    The 8 most recent earnings calls are listed below; the latest, 2026Q3 for the period ended Sep 30, 2026, runs about 6,600 words across 11 speakers.

    CallPeriod endingWordsSpeakersTranscript
    2026Q3Sep 30, 20266,55911
    2026Q2Jun 30, 20266,00010
    2026Q1Mar 31, 20264,43610
    2025Q4Dec 31, 20259,51112
    2025Q3Sep 30, 20251,81411
    2025Q2Jun 30, 20257,70812
    2025Q1Mar 31, 20252,72510
    2024Q4Dec 31, 20248,64512

    2026Q3 Earnings Call

    Opening remarks

    Christopher Reading Chairman and CEO Good morning, and welcome to U.S. Physical Therapy's third quarter 2026 earnings call. With me today are Nchacha Etta, our EVP and new Chief Financial Officer; Eric Williams, President and COO East; Graham Reeve, COO West; Rick Binstein, our General Counsel; and Jason Curtis, our Senior Vice President of Accounting and Finance. Before we get started, Jason will read our disclosure statement. Jason, if you would, please.

    Jason Curtis Senior Vice President of Accounting and Finance Thank you, Chris. The presentation includes forward-looking statements, which involve certain risks and uncertainties. These forward-looking statements are based on the company's current views and assumptions. The company's actual results may vary materially from those anticipated. Please see the company's filings with the Securities and Exchange Commission for more information. This presentation also includes certain non-GAAP measures as defined in Regulation G, and the related reconciliation can be found in the company's earnings release and the company's presentation on our website.

    Christopher Reading Chairman and CEO Thanks, Jason. This is Nchacha's first earnings call with us. He has been on many during a distinguished public company career. Nchacha, welcome. We are thrilled to have you, and we look forward to introducing you more personally to our analysts and shareholders in the days ahead. As always, I want to start by thanking our partners and our clinical and support teams. Their work changes lives for our patients across our physical therapy partnerships. It also keeps employees healthy and on the job at many of our nation's largest and most successful employers through our injury prevention teams. Our physical therapy business starts with great care, and that care delivers real value to the broader health care system. Even for Medicare-age patients, completing an outpatient physical therapy plan of care is associated with lower total health care spending the following year, according to a study commissioned by APTQI in 2017 and independently performed by the Maran Group. Great care is what lets us grow volume every year across a growing clinic base. This quarter is often a seasonally softer quarter as referral sources and staff vacations kick in. But we held steady this summer at more than 33 visits per clinic per day right through the quarter, compared with 32 a year ago. We set a couple of important records this quarter. With respect to visits, every month this year has been a record for that month. We are up to 27 consecutive months where that has occurred—nearly 2.5 years of record volume each and every month. We did this while our operations and clinical teams completed a very major lift in this third quarter. All of the Metro New York facilities moved into our NYU Langone relationship, and the majority of that lift occurred in the third quarter.

    Frequently Asked Questions About USPH

    When is U.S. Physical Therapy's next earnings date?

    U.S. Physical Therapy's next earnings report is expected for Feb 23, 2027.

    Did USPH beat earnings estimates last quarter?

    Yes. U.S. Physical Therapy reported EPS of $0.80 for the quarter ended Sep 30, 2026, above the $0.76 estimate, a 5.26% surprise.

    What EPS do analysts expect from USPH next quarter?

    The consensus EPS estimate for U.S. Physical Therapy for the quarter ending Dec 31, 2026 is $0.90 from 9 analysts, with estimates from $0.76 to $1.04.

    How often does USPH beat earnings estimates?

    U.S. Physical Therapy beat the EPS estimate in 3 of the last 8 quarters, with an average surprise of -2.85%.